GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum

Neuroscience Letters

Volumn 225, Issue 3, 1997, Pages 145-148

  Malcon, César ^a   Achaval, Matilde ^a   Komlos, Fábio ^a   Partata, Wania ^a   Sauressig, Maurício ^a   Ramírez, Galo ^b   Souza, Diogo O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

excitotoxicity; GMP; guanine nucleotides; Huntington's disease; neuroprotection; quinolinic acid; rat striatum

Indexed keywords

DIZOCILPINE; EXCITOTOXIN; GUANOSINE PHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; QUINOLINIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

5'-GUANYLIC ACID; ANIMALS; MALE; NADPH DEHYDROGENASE; QUINOLINIC ACID; RATS; RATS, WISTAR; VISUAL CORTEX;

EID: 0030894326     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00225-5     Document Type: Article

References (22)

1. Baron, B.N., Dudley, M.W., McCarty, D.R., Miller, F.P., Reynolds, I.J. and Schmidt, C.J., Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo, J. Pharmacol. Exp. Ther., 250 (1989) 162-169.
2. Beal, M.F., Ferrante, R.J., Swartz, K.J. and Kowall, N.W., Chronic quinolinic acid lesions in rats closely resemble Huntington's disease, J. Neurosci., 11 (1991) 1649-1659.
3. Boegman, R.J., Smith, Y. and Parent, A., Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons, Brain Res., 415 (1987) 178-182.
4. Davies, S.W. and Roberts, P.J., No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid, Nature, 327 (1987) 326-329.
5. Dawbarn, D., DeQuidt, M.E. and Emson, P.L., Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease, Brain Res., 340 (1985) 251-260.
6. Ferrante, R.J., Kowall, N.W., Beal, M.F. and Richardson, E.P., Jr, Bird, E.D. and Martin, J.B., Selective sparing of a class of striatal neurons in Huntington's disease, Science, 230 (1985) 561-563.
7. Foster, A.C., Gill, R. and Woodruff, G.N., Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation, J. Neurosci., 8 (1988) 4745-4754.
8. Gorodinsky, A., Paas, Y. and Teichberg, V.I., A ligand binding study of the interactions of guanine nucleotides with non-NMDA receptors, Neurochem. Int., 23 (1993) 285-291.
9. Koh, J.Y., Peters, S. and Choi, D.W., Neurons containing NADPH-diaphorase are selective resistant to quinolinate toxicity, Science, 234 (1986) 73-76.
10. Lipton, S.A. and Rosenberg, P.A., Excitatory amino acids as a final common pathway for neurologic disorders, N. Engl. J. Med., 330 (1994) 613-622.
11. Martin, J.B., Huntington's disease: new approaches to an old problem, Neurology, 4 (1984) 1059-1072.
12. Monahan, J.B., Hood, W.F., Michel, J. and Compton, R.P., Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions, Mol. Pharmacol., 34 (1988) 111-116.
13. Moroni, F., Lombardi, G., Moneti, G. and Aldinio, C., The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process, Neurosci Lett., 47 (1984) 51-55.
14. Nakanishi, S., Molecular diversity of glutamate receptors and implications for brain function, Science, 258 (1992) 597-603.
15. Paz, M.M., Ramos, M., Ramírez, G. and Souza, D., Differential effects of guanine nucleotides on kainic acid binding and on adenylate cyclase activity in chick optic tectum, FEBS Lett., 355 (1994) 205-208.
16. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
17. Popoli, P., Pezzola, A., Domenici, M.R., Sagratella, S., Diana, G., Caporale, M.G., Bronzetti, E., Vega, J. and Scotti de Carolis, A., Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease, Brain Res. Bull., 35 (1994) 329-335.
18. Souza, D.O. and Ramírez, G., Effects of guanine nucleotides on kainic acid binding and on adenylate cyclase in chick optic tectum and cerebellum, J. Mol. Neurosci., 3 (1991) 39-45.
19. Tasca, C., Wofchuck, S., Souza, D., Ramírez, G. and Rodnight, R., Guanine nucleotides inhibit the stimulation of GFAP phosphorylation by glutamate, NeuroReport, 6 (1995) 249-252.
20. Valtschanoff, J.G., Weinberg, R.J., Kharazia, V.N., Nakane, M. and Schmidt, H.H.W., Neurons in rat hippocampus that synthesize nitric oxide, J. Comp. Neurol., 331 (1993) 111-121.
21. Vincent, S.R., Johansson, O., Hökfelt, T. and Skirboll, C., Elde, R.P., Terenius, L., Kimmel, J. and Goldstein, M., NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivities, J. Comp. Neurol., 217 (1983) 252-263.
22. Vornov, J.J., Tasker, R.C. and Coyle, J.T., The differential neurotoxicity of endogenous and exogenous excitatory neurotransmitter receptor agonists. In A. Harvey (Ed.), Natural and Synthetic Neurotoxins, Academic Press, London, 1993, pp. 187-224.